| Affiliation: | 1. Department of Rehabilitation and Geriatrics, Faculty of Medicine, University of Geneva, Geneva University Hospitals, Geneva, Switzerland;2. Hôpital d’Instruction des Armées Bégin, Saint-Mandé, France;3. CHU de Bordeaux, Pessac, UMR 5536 CNRS, université Victor-Segalen–Bordeaux-2, Bordeaux, France;4. Hôpitaux universitaires de Strasbourg, université de Strasbourg, Strasbourg, France;5. CHRU de Tours, université François-Rabelais, Tours, France;6. French Institute for Public Health Surveillance, institut de veille sanitaire, Saint-Maurice, France;7. Centre hospitalier de Compiègne, Compiègne, France;8. Hôpital Sainte-Marguerite, AP–HM, Marseille, France;9. Hôpital La Pitié-Salpêtrière, AP–HP, Paris, France;10. Biogerontology Laboratory, Research Center on Aging, Sherbrooke Geriatric University Institute, Sherbrooke, Canada;11. CHU de Bicêtre, AP–HP, Le Kremlin-Bicêtre, France;12. CHU de Rouen, université de Rouen, Rouen, France |
| Abstract: | The prevalence of type 2 diabetes increases with age. However, the management of diabetes in the elderly has received surprisingly little attention. Diabetes in the elderly is associated with a high risk of geriatric syndromes including malnutrition and sarcopenia, functional impairments, falls and fractures, incontinence, depression and dementia. Tight glycaemic control for the prevention of vascular complications is often of limited value in the elderly. However, glycaemic control and non-pharmacological therapy may prevent diabetes symptoms and delay geriatric syndromes. The prevention, screening and treatment of both conventional diabetic complications and geriatric syndromes should be integrated in a management plan to optimize the patients’ overall health status and quality of life. |
